GB983810A - Improved tablet - Google Patents
Improved tabletInfo
- Publication number
- GB983810A GB983810A GB1882963A GB1882963A GB983810A GB 983810 A GB983810 A GB 983810A GB 1882963 A GB1882963 A GB 1882963A GB 1882963 A GB1882963 A GB 1882963A GB 983810 A GB983810 A GB 983810A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sections
- section
- intersection
- upper face
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 abstract 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 abstract 2
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 abstract 2
- 229960002695 phenobarbital Drugs 0.000 abstract 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- TZRXHJWUDPFEEY-UHFFFAOYSA-N Pentaerythritol Tetranitrate Chemical compound [O-][N+](=O)OCC(CO[N+]([O-])=O)(CO[N+]([O-])=O)CO[N+]([O-])=O TZRXHJWUDPFEEY-UHFFFAOYSA-N 0.000 abstract 1
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 abstract 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 abstract 1
- HRYJPHOTGFERGT-UHFFFAOYSA-N Thonzylamine hydrochloride Chemical compound Cl.C1=CC(OC)=CC=C1CN(CCN(C)C)C1=NC=CC=N1 HRYJPHOTGFERGT-UHFFFAOYSA-N 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 235000011132 calcium sulphate Nutrition 0.000 abstract 1
- 239000001175 calcium sulphate Substances 0.000 abstract 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 229960004321 pentaerithrityl tetranitrate Drugs 0.000 abstract 1
- 229960003893 phenacetin Drugs 0.000 abstract 1
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 abstract 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 abstract 1
- 229960000581 salicylamide Drugs 0.000 abstract 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 1
- 229960004674 theophylline anhydrous Drugs 0.000 abstract 1
- 229960004636 thonzylamine hydrochloride Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEW0034607 | 1963-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB983810A true GB983810A (en) | 1965-02-17 |
Family
ID=7600649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1882963A Expired GB983810A (en) | 1963-05-28 | 1963-05-13 | Improved tablet |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE632692A (enrdf_load_stackoverflow) |
| DE (1) | DE1492237A1 (enrdf_load_stackoverflow) |
| GB (1) | GB983810A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454108A (en) * | 1981-09-04 | 1984-06-12 | Chugai Seiyaku Kabushiki Kaisha | Prolonged-action multiple-layer tablets |
| EP0126453A3 (en) * | 1983-05-19 | 1986-07-09 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
| AU587255B2 (en) * | 1985-06-04 | 1989-08-10 | Sandoz Ltd. | Pharmaceutical tablet |
| GB2518955A (en) * | 2013-08-07 | 2015-04-08 | Kraft Foods R & D Inc | Comestible product |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4353887A (en) * | 1979-08-16 | 1982-10-12 | Ciba-Geigy Corporation | Divisible tablet having controlled and delayed release of the active substance |
| DE3314003A1 (de) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung |
| DE19837684A1 (de) * | 1998-08-19 | 2000-02-24 | Knoll Ag | Exakt teilbare Tablette |
-
0
- BE BE632692D patent/BE632692A/xx unknown
-
1963
- 1963-05-13 GB GB1882963A patent/GB983810A/en not_active Expired
- 1963-05-28 DE DE19631492237 patent/DE1492237A1/de active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4454108A (en) * | 1981-09-04 | 1984-06-12 | Chugai Seiyaku Kabushiki Kaisha | Prolonged-action multiple-layer tablets |
| EP0126453A3 (en) * | 1983-05-19 | 1986-07-09 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
| AU567940B2 (en) * | 1983-05-19 | 1987-12-10 | Merrell Dow Pharmaceuticals Inc. | Controlled release tablet |
| AU587255B2 (en) * | 1985-06-04 | 1989-08-10 | Sandoz Ltd. | Pharmaceutical tablet |
| GB2518955A (en) * | 2013-08-07 | 2015-04-08 | Kraft Foods R & D Inc | Comestible product |
| GB2518955B (en) * | 2013-08-07 | 2020-05-27 | Kraft Foods Schweiz Holding Gmbh | Comestible product |
| EP3030089B1 (en) * | 2013-08-07 | 2020-10-28 | Kraft Foods Schweiz Holding GmbH | Comestible product |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1492237A1 (de) | 1969-09-18 |
| BE632692A (enrdf_load_stackoverflow) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR830001639A (ko) | 다분할성 정제구조물 | |
| GB1204580A (en) | Pharmaceutical dosage forms | |
| GB983810A (en) | Improved tablet | |
| GB1221393A (en) | Improvements in or relating to hepato-protective drugs | |
| GB1380171A (en) | Medicinal tablets | |
| DE2963990D1 (en) | Analgesic tablet and process for its preparation | |
| GB1502873A (en) | Pharmaceutical compositions with ulcer healing activity | |
| ES2088550T3 (es) | Recubrimientos que ocultan el sabor para preparar comprimidos farmaceuticos masticables. | |
| IL51360A (en) | Peptides having analgesic activity,their production and pharmaceutical compositions containing them | |
| FR1259081A (fr) | Procédé pour la préparation d'un produit à particules sèches notamment à partir d'une solution colloïdale | |
| GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
| GB1195534A (en) | Drug Packs | |
| FR2391202A1 (fr) | Triazines-1,2,4 substituees, actives pharmacologiquement et medicaments contenant ces triazines | |
| GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
| GB1387643A (en) | Divisible tablet | |
| GB1126153A (en) | Novel polygalacturonic acid derivative | |
| GB1341376A (en) | Pharmaceutical compositions comprising 4-methyl-5-2-aminoethyl imidazole | |
| IE35419B1 (en) | Muscle-relaxant compositions | |
| GB1287433A (en) | Pharmaceutical compositions | |
| IE33949B1 (en) | Compositions for treating gastrointestinal disorders | |
| GB1153324A (en) | Sustained Release Tablets | |
| GB1021070A (en) | A new triazolone and a process for its preparation | |
| GB1212115A (en) | Pharmaceutical composition comprising magnesium acetylsalicylate and method for preparing same | |
| FR2293205A2 (fr) | Medicament utile notamment comme vasodilatateur, procede de preparation de ses substances actives et ces substances elles-memes | |
| BE747274R (fr) | Procedes de preparation de composes d'aminocarbonylalkyle n-substitues et n,n-disubstitues et nouveaux produits ainsi obtenus |